Article thumbnail

Provider Discussion, Education, and Question-Asking about Control Medications during Pediatric Asthma Visits

By Betsy Sleath, Delesha M. Carpenter, Guadalupe X. Ayala, Dennis Williams, Stephanie Davis, Gail Tudor, Karin Yeatts and Chris Gillette


Background. Few studies have explored how providers communicate about control medications during pediatric asthma visits. Objectives. The purpose of this study was to: (a) describe the extent to which providers discuss, educate, and ask children and their caregivers questions about control medications and (b) examine how child, caregiver, and provider characteristics are associated with provider communication about control medications during pediatric asthma visits. Methods. Children ages 8 through 16 with mild, moderate, or severe persistent asthma and their caregivers were recruited at five pediatric practices in nonurban areas of North Carolina. After audio-tape recording medical visits, caregivers completed questionnaires and children were interviewed. Generalized estimating equations were used to analyze the data. Results. Providers educated families about control medications during 61% of the visits, and they asked questions about control medications during 67% of visits. Providers were significantly more likely to discuss control medications if a child was taking a control medication, if the child had moderate to severe persistent asthma, and if the child was present for an asthma-related visit. Conclusion. Providers need to educate and ask more questions of families about side effects and how well control medications are working

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1998). Adherence with twice-daily dosing of inhaled steroids,”
  2. (2006). Akinbami and Centers for Disease Control and Prevention National Center for Health Statistics, “The state of childhood asthma,UnitedStates,1980–2005,”Advance Data,vol.381,pp.
  3. (1999). Asking questions about medication: analysis of physician-patient interactions and physician perceptions,”
  4. (2007). Education and Prevention Program, “Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report,”
  5. (1997). for the diagnosis and management of Asthma,” Expert
  6. (2002). Guidelines for the diagnosis and management of Asthma,” Expert panel report, National Institutes of Health,
  7. (2005). Keeping children with asthma out of hospitals: parents’ and physicians’ perspectives on how pediatric asthma hospitalizations can be prevented,”
  8. (2000). M a n s o u r ,B .P .L a n p h e a r ,a n dT
  9. (2000). Nocturnal asthma in children affects school attendance, school performance, and parents’workattendance,”ArchivesofPediatricsandAdolescent Medicine,
  10. (2003). Parental perceptions of their child’s asthma: managementandmedicationuse,”JournalofPediatricHealthCare,
  11. (2009). Physician communication and patient adherence to treatment: a meta-analysis,”
  12. (1985). Physician communication to patients regarding medications,”
  13. (2007). Providerpatientcommunicationaboutantidepressantsamongveterans with mental health conditions,”
  14. (2007). S c h m i e r ,R .M a n j u n a t h ,M .T .H a l p e r n ,M .L .J o n e s
  15. (2009). Socioeconomic, family, and pediatric practice factors that affect level of asthma control,”
  16. (2010). Suboptimal use of inhaled corticosteroids in childrenwithpersistentasthma:inadequateprescription,poor drug adherence,
  17. (2009). The impact of uncontrolled asthma on absenteeism and health-related quality of life,”
  18. (2006). Types of information physicians provide when prescribing antidepressants,”